Pancreatic cancer belongs to the most malignant gastrointestinal cancers and the treatment options are limited. The two bioactive components of turmeric, curcumin and turmeric oil, are reported to have anticancer properties against pancreatic cancer as well as a number of other cancer cell lines. These turmeric products make use of a number of different signaling pathways in their mechanism of action. The low toxicity of these components and their ability to enhance the activity of other anti-cancer drugs make them good candidates for the development of new treatment options for pancreatic cancer. A brief review of the current state of these compounds in pancreatic cancer research is presented.